Management of new technologies
New technologies such as plant biotechnology or nanotechnology offer solutions for key societal challenges – for example, in the areas of climate protection or health and nutrition. We engage in open dialog with our stakeholders on opportunities and risks and inform in a transparent manner.
Our Nanotechnology Code of Conduct sets out principles for using nanomaterials. Over the last few years, we have conducted more than 100 toxicological and ecotoxicological studies and participated in around 27 different projects related to safety research. The NanoGEM project, for example, investigates the lifecycle of functionalized nanoparticles and nanocomposite material. In Europe, we participate in endeavors like the MARINA joint project of the European Union Commission to establish reference methods and a test strategy for nanomaterials safety.
We launched a joint safety research project in 2012 with the German Federal Ministry for the Environment, Nature Conservation and Nuclear Safety (BMU) and the Federal Institute for Occupational Safety and Health (BAuA). The goal of the study is to explore the long-term effects of various nanomaterials. We published the results of our safety research in around 40 professional periodicals as well as online. Moreover, we enhanced our internal risk management in 2012, defining, for example, new requirements for the handling of nanomaterials. Furthermore, in a global Group directive, we added new requirements for identifying nanomaterials.
In the use of biotechnology, we follow the code of conduct of “EuropaBio,” the European association for biotechnology industries. We continued to improve our product safety activities in the field of biotechnology in 2012, enabling us to minimize potential risks even more efficiently and ensure that all standards and national laws are met. Our internal risk management is based on the protection of people, animals and the environment. In 2012, we implemented the “Project Risk Score Card” system, which monitors the risks of dealing with biotechnology. It ensures compliance with standards and transparent processes at BASF.